People

In 2017, Mayo Clinic launched a first-in-the-U.S. clinical test to help patients with some autoimmune disorders get the right diagnosis faster. The test defines a new form of inflammatory demyelinating disease, called myelin oligodendrocyte glycoprotein autoimmunity, which is distinct from multiple sclerosis, with which it is commonly confused.

This year marks the 50th anniversary of the death of Dr. Charles W. Mayo, “Dr. Chuck.” A recent article in the Post-Bulletin highlights the tributes that came in from around the world.

Each month, this series will focus on Mayo Clinic’s values and feature quotes and stories from our founders that exemplify those values. This month's featured value is Teamwork.

At 104 years old, Sylvia Molstre had accumulated a few stories. And a few scars. And a few stories about scars. Like the tiny scar that marks the spot where she had her appendix removed one Sunday afternoon by "Dr. Chuck," also known as Charles William Mayo, M.D., son of Dr. Charlie Mayo.

Robin Patel, M.D., Chair of the Division of Clinical Microbiology, has been appointed as a founding member of the new Institute for Antimicrobial Resistance Research and Education.

Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Laboratory Medicine and Pathology, answers questions about the rat lungworm.

At the 2018 American Association for Clinical Chemistry annual meeting in Chicago, Nikola Baumann, Ph.D., presented about how biotin can sometimes interfere with laboratory measurements.

Mike Baisch, a principal systems engineer at Mayo Clinic, authored an article in MedicalLab Management on staffing to workload in the laboratory. In the article, he talks about the necessity to place the right people in the right place at the right time in order for the laboratory to excel.

Dick Garbisch hit a milestone that not many do: his 100th birthday. For 90 of those years, Mayo Clinic has been a part of his story.

The Mayo Clinic Board of Trustees announced on August 10 that it has elected Gianrico Farrugia, M.D., Vice President and CEO of Mayo Clinic in Florida to succeed John Noseworthy, M.D., as president and CEO of Mayo Clinic. Dr. Noseworthy remains President and CEO through his retirement at the end of the year. Drs. Noseworthy and Farrugia will work closely together through this period of transition.

At the 2018 American Association for Clinical Chemistry annual meeting in Chicago, Mayo Clinic experts discussed how laboratories can stay viable and competitive under the reimbursement model.

Mayo Clinic carves out a section of its History of Medicine Library for part of recovering bibliophile's collection and renames the library in his honor.

The Washington Post recently reported on hookworms burrowing into a teenager's skin during a trip to Florida. Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services at Mayo Clinic, commented on the two main types of hookworm: human hookworms and animal, or "zoonotic," hookworms.